Publication | Closed Access
215 Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib
10
Citations
0
References
2014
Year
Preliminary Correlative ResultsMedicineGynecologyPathologyCancer TreatmentPhase 2OncologyGynecology OncologyEndocrine-related CancerOvarian Cancer PatientsOvarian Cancer
No additional data available for this publication yet. Check back later!